Population differences in antibody response to SARS‐CoV‐2 infection and BNT162b2 vaccination

The concentration of SARS‐CoV‐2‐specific serum antibodies, elicited by vaccination or infection, is a primary determinant of anti‐viral immunity, which correlates with protection against infection and COVID‐19. Serum samples were obtained from 25 897 participants and assayed for anti‐SARS‐CoV‐2 spik...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2022-04, Vol.36 (4), p.e22223-n/a
Main Authors: Shapira, Guy, Abu Hamad, Ramzia, Weiner, Chen, Rainy, Nir, Sorek‐Abramovich, Reut, Benveniste‐Levkovitz, Patricia, Rock, Rachel, Avnat, Eden, Levtzion‐Korach, Osnat, Bar Chaim, Adina, Shomron, Noam
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
antibodies
Antibodies, Viral - blood
BNT162 Vaccine - immunology
Child
Child, Preschool
Cohort Studies
COVID-19 - prevention & control
COVID-19 - virology
COVID‐19
Female
Humans
Immunoglobulin G - blood
Infant
Israel
Male
Middle Aged
SARS-CoV-2 - immunology
SARS‐CoV‐2
severity
vaccination
vaccine
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The concentration of SARS‐CoV‐2‐specific serum antibodies, elicited by vaccination or infection, is a primary determinant of anti‐viral immunity, which correlates with protection against infection and COVID‐19. Serum samples were obtained from 25 897 participants and assayed for anti‐SARS‐CoV‐2 spike protein RBD IgG antibodies. The cohort was composed of newly vaccinated BNT162b2 recipients, in the first month or 6 months after vaccination, COVID‐19 patients and a general sample of the Israeli population. Antibody levels of BNT162b2 vaccine recipients were negatively correlated with age, with a prominent decrease in recipients over 55 years old, which was most significant in males. This trend was observable within the first month and 6 months after vaccination, while younger participants were more likely to maintain stable levels of serum antibodies. The antibody concentration of participants previously infected with SARS‐CoV‐2 was lower than the vaccinated and had a more complex, non‐linear relation to age, sex and COVID‐19 symptoms. Taken together, our data supports age and sex as primary determining factors for both the magnitude and durability of humoral response to SARS‐CoV‐2 infection and the COVID‐19 vaccine. Our results could inform vaccination policies, prioritizing the most susceptible populations for repeated vaccination.
ISSN:0892-6638
1530-6860
DOI:10.1096/fj.202101492R